<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intermittent explosive disorder in adults: Epidemiology and pathogenesis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intermittent explosive disorder in adults: Epidemiology and pathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Intermittent explosive disorder in adults: Epidemiology and pathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Emil Coccaro, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan McElroy, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Solomon, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 16, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3271572692"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Patients with intermittent explosive disorder have impulsive, aggressive verbal outbursts at least twice a week and serious, physically assaultive behavior at least three times a year [<a href="#rid1">1-3</a>]. The aggressive behaviors are unplanned, out of proportion to the provocation, and cause subjective distress or psychosocial impairment.</p><p>This topic reviews the epidemiology and pathogenesis of intermittent explosive disorder. The clinical features, assessment, diagnosis, treatment, and prognosis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14750.html" rel="external">"Intermittent explosive disorder in adults: Clinical features, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/16694.html" rel="external">"Intermittent explosive disorder in adults: Treatment and prognosis"</a>.)</p><p class="headingAnchor" id="H1003937524"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Estimates of the lifetime prevalence of intermittent explosive disorder range from 1 to 7 percent, depending upon the study population [<a href="#rid4">4,5</a>]. However, the prevalence of intermittent explosive disorder is not well established because most studies [<a href="#rid5">5</a>] relied upon diagnostic criteria from the American Psychiatric Association’s Diagnostic and Statistical Manual, Fourth Edition (DSM-IV) [<a href="#rid6">6</a>], rather than the more recent Diagnostic and Statistical Manual, Fifth Edition (DSM-5) [<a href="#rid3">3</a>]. The DSM-IV criteria had several limitations, such as not requiring that the aggressive behavior be impulsive rather than planned, not providing operationalized criteria on the nature and frequency of impulsive aggressive behavior, and not clearly specifying exclusionary disorders [<a href="#rid2">2,7</a>].</p><p class="headingAnchor" id="H691421505"><span class="h2">General population</span><span class="headingEndMark"> — </span>Using various diagnostic criteria, nationally representative surveys of the general adult population in different countries estimate that the lifetime prevalence of intermittent explosive disorder is 1 to 4 percent  (<a class="graphic graphic_table graphicRef67143" href="/z/d/graphic/67143.html" rel="external">table 1</a>) [<a href="#rid8">8-12</a>]. The estimated 12-month prevalence ranges from 1 to 3 percent [<a href="#rid8">8,9,11-14</a>].</p><p>A survey in the United States, using diagnostic criteria from DSM-5 [<a href="#rid3">3</a>], found that the lifetime prevalence of intermittent explosive disorder was approximately 4 percent and the past-year prevalence was close to 3 percent [<a href="#rid15">15</a>]. The survey also found that the lifetime and past-year prevalence of serious, physically assaultive behavior at least three times a year (one of the DSM-5 criteria) was approximately 8 and 6 percent [<a href="#rid16">16</a>].</p><p>The DSM-5 diagnostic criteria for intermittent explosive disorder are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14750.html" rel="external">"Intermittent explosive disorder in adults: Clinical features, assessment, and diagnosis", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H2943866868"><span class="h3">Sociodemographic correlates</span><span class="headingEndMark"> — </span>Onset of intermittent explosive disorder often occurs at an early age. In a cross-national study of community surveys from 16 countries, the median age of onset was 17 years; in the United States, the median age of onset was 14 years [<a href="#rid5">5</a>].</p><p>Community surveys show that the disorder occurs more often in males and younger individuals (eg, age &lt;60 years) [<a href="#rid5">5</a>]. In addition, the disorder is modestly associated with being divorced or separated, unemployed, and not finishing college.</p><p class="headingAnchor" id="H3603819933"><span class="h2">Clinical settings</span><span class="headingEndMark"> — </span>The estimated lifetime prevalence of intermittent explosive disorder in psychiatric patients is 6 to 7 percent, and the point (current) prevalence is 3 to 6 percent:</p><p class="bulletIndent1"><span class="glyph">●</span>A study of 1300 outpatients found that the lifetime prevalence of intermittent explosive disorder was 6 percent, and the point prevalence was 3 percent [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of 204 inpatients found that the lifetime prevalence of intermittent explosive disorder was 7 percent, and the point prevalence was 6 percent [<a href="#rid4">4</a>].</p><p></p><p class="headingAnchor" id="H325403521"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of intermittent explosive disorder is not known. Many authorities think that the etiology involves biologic, psychological, and social factors [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H3720918158"><span class="h2">Genetics</span><span class="headingEndMark"> — </span>There is probably a genetic component to intermittent explosive disorder [<a href="#rid19">19-22</a>]. A study using blinded raters found a positive family history of intermittent explosive disorder in more first-degree relatives (parents, siblings, or offspring) of patients with the disorder (n = 32) than in relatives of nonaggressive controls (n = 32; 34 versus 10 percent) [<a href="#rid23">23</a>]. In addition, twin and family studies suggest that 44 to 72 percent of the likelihood of developing impulsive aggressive behavior is genetic [<a href="#rid18">18</a>]. This is consistent with a meta-analysis of 24 twin and adoption studies of aggression (number of subjects not specified), which found that genetic factors accounted for approximately 50 percent of the variance in aggression [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H870267523"><span class="h2">Neurobiology</span><span class="headingEndMark"> — </span>Multiple lines of evidence demonstrate that brain structure and function are altered in intermittent explosive disorder. As an example, structural, functional, and connectivity brain magnetic resonance imaging studies suggest that the amygdala, which is involved in emotional functioning, is affected. However, it is not clear whether the observed abnormalities represent etiologic causes, sequelae, neither, or both.</p><p class="headingAnchor" id="H1535080660"><span class="h3">Neuroimaging</span><span class="headingEndMark"> — </span>Impulsive, aggressive behavior has been conceptualized as an imbalance between excessive, aggressive drives originating in limbic brain structures such as the amygdala, and insufficient control of these impulses by cortical structures such as the orbital frontal cortex and anterior cingulate cortex [<a href="#rid18">18</a>]. Support for this hypothesis includes functional magnetic resonance imaging studies that presented photographs of angry faces to patients with intermittent explosive disorder and healthy controls [<a href="#rid25">25,26</a>]. Compared with controls, patients exhibited increased activation of the amygdala and reduced activation of the orbitofrontal cortex. However, this finding may be present only in the context of social threat [<a href="#rid27">27</a>].</p><p>Other brain magnetic resonance imaging studies in patients with intermittent explosive disorder have also found abnormalities in the amygdala, as well as other areas:</p><p class="bulletIndent1"><span class="glyph">●</span>Structural imaging of 67 individuals with intermittent explosive disorder and 73 healthy controls found that intermittent explosive disorder was associated with greater localized, inwardly directed deformations in the shape of the amygdala and hippocampus [<a href="#rid28">28</a>]. The deformations suggested loss of neurons.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Structural imaging found that the volume of the amygdala and other gray matter structures (eg, orbitofrontal cortex and anterior cingulate cortex) was smaller in individuals with intermittent explosive disorder (n = 57), compared with healthy controls (n = 53) and with individuals with other psychiatric disorders (eg, depressive or anxiety disorders; n = 58) [<a href="#rid29">29</a>]. In addition, frontal-limbic gray matter volume across all subjects was inversely related to aggressive behavior and tendencies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Connectivity imaging found that integrity of white matter tracts between the frontal and temporoparietal regions was reduced in intermittent explosive disorder (n = 42), compared with healthy controls (n = 40) and psychiatric controls (n = 50) [<a href="#rid30">30</a>].</p><p></p><p class="headingAnchor" id="H4076519176"><span class="h3">Serotonergic activity</span><span class="headingEndMark"> — </span>On a molecular level, multiple studies suggest that serotonergic activity in patients with intermittent explosive disorder is reduced [<a href="#rid2">2,31</a>]. As an example:</p><p class="bulletIndent1"><span class="glyph">●</span>A study examined the number of platelet serotonin binding sites as a proxy for central nervous system serotonin activity and found fewer binding sites in 35 patients with intermittent explosive disorder, compared with 65 controls [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study found that response to a single dose of the serotonin releasing agent dexfenfluramine was significantly reduced in 62 patients with intermittent explosive disorder, compared with 38 controls [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One positron emission tomography study found less serotonergic innervation in the anterior cingulate cortex in 10 patients with intermittent explosive disorder, compared with 10 healthy controls [<a href="#rid34">34</a>]. While a second larger study (n = 29 patients and 30 controls) did not replicate this finding, the second study reported an inverse relationship between state aggression levels and serotonin transporter availability in subcortical regions (striatum and thalamus) [<a href="#rid35">35</a>].</p><p></p><p class="headingAnchor" id="H2995895227"><span class="h3">Inflammation</span><span class="headingEndMark"> — </span>Serum inflammatory proteins appear to be elevated in patients with intermittent explosive disorder. A study compared C-reactive protein and interleukin 6 levels in patients with intermittent explosive disorder (n = 69), healthy controls (n = 67), and nonaggressive patients with other psychiatric disorders (n = 61); all subjects were physically healthy, and the analyses controlled for several potential confounding factors (age, body mass index, depression, and psychological stress) [<a href="#rid36">36</a>]. Levels of both inflammatory markers were higher in patients with intermittent explosive disorder compared with healthy and psychiatric controls, and were directly correlated with a composite measure of aggression. This was not due to differences in tryptophan-kynurenine pathway metabolites [<a href="#rid37">37</a>].</p><p>In an overlapping group of study participants, individuals with intermittent explosive disorder displayed increased concentrations of serum markers of oxidative stress, compared with healthy controls and with psychiatric controls [<a href="#rid38">38</a>]. Oxidative stress, which is an inherent part of inflammation, could account for possible cellular damage in the central nervous system (eg, reduced gray matter).</p><p>A subsequent study of gene expression included patients with intermittent explosive disorder (n = 45) and both psychiatric and healthy controls (n = 79) [<a href="#rid39">39</a>]. The results found that intermittent explosive disorder has a distinct immunoregulatory profile, including upregulated activity for antiviral response, suggesting that its etiology may involve a pathogen-driven immune response.</p><p class="headingAnchor" id="H1243529860"><span class="h3">Infection</span><span class="headingEndMark"> — </span>Infection with <em>Toxoplasma gondii</em>, which can localize in brain tissue, may be associated with intermittent explosive disorder. One study found that seropositivity to <em>Toxoplasma gondii</em> antibodies occurred in more individuals with a lifetime diagnosis of intermittent explosive disorder (n = 110) than healthy controls (n = 110; 22 versus 9 percent) [<a href="#rid40">40</a>]. In addition, aggressive behavior and tendencies, as assessed across all subjects, were greater in seropositive individuals than seronegative individuals.</p><p class="headingAnchor" id="H429939356"><span class="h2">Psychosocial factors</span><span class="headingEndMark"> — </span>Family environment and exposure to multiple traumas (eg, physical abuse and witnessing family violence as a child) may be involved in the pathogenesis of intermittent explosive disorder [<a href="#rid18">18</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A cross-national study of community surveys from 16 countries found that after controlling for potential confounding factors (eg, age, sex, and country), onset of intermittent explosive disorder was more than twice as likely among individuals with a prior, childhood history of physical abuse or witnessing family violence [<a href="#rid5">5</a>]. In addition, the association between trauma and subsequent onset of intermittent explosive disorder became larger as individuals suffered an increasing number of different types of trauma.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective study found that a history of sexual abuse, physical abuse or neglect, or emotional abuse or neglect was more extensive in patients with a lifetime history of intermittent explosive disorder (n = 264) than patients with other psychiatric disorders (n = 199) and healthy controls (n = 185) [<a href="#rid41">41</a>].</p><p></p><p class="headingAnchor" id="H4049463777"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Intermittent explosive disorder is characterized by recurrent, impulsive aggressive behavior that is distinguished from both premeditated aggression as well as defensive aggression provoked by an immediate threat. (See  <a class="medical medical_review" href="/z/d/html/14750.html" rel="external">"Intermittent explosive disorder in adults: Clinical features, assessment, and diagnosis", section on 'Aggression'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>General population surveys estimate that the lifetime prevalence of intermittent explosive disorder is 1 to 4 percent  (<a class="graphic graphic_table graphicRef67143" href="/z/d/graphic/67143.html" rel="external">table 1</a>); the prevalence in clinical settings is 6 to 7 percent. The median age of onset is approximately 17 years, and the disorder occurs more often in males and individuals aged less than 60 years. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Although the pathogenesis of intermittent explosive disorder is not known, there appears to be a genetic component. In addition, structural, functional, and connectivity brain magnetic resonance imaging studies suggest that the amygdala and other brain areas are involved. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Several treatments are available for intermittent explosive disorder. (See  <a class="medical medical_review" href="/z/d/html/16694.html" rel="external">"Intermittent explosive disorder in adults: Treatment and prognosis"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Coccaro EF. Intermittent explosive disorder: development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Compr Psychiatry 2011; 52:119.</a></li><li><a class="nounderline abstract_t">Coccaro EF. Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5. Am J Psychiatry 2012; 169:577.</a></li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.</li><li><a class="nounderline abstract_t">Grant JE, Levine L, Kim D, Potenza MN. Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 2005; 162:2184.</a></li><li><a class="nounderline abstract_t">Scott KM, Lim CC, Hwang I, et al. The cross-national epidemiology of DSM-IV intermittent explosive disorder. Psychol Med 2016; 46:3161.</a></li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), Fourth edition, Text revision, American Psychiatric Association, Washington, DC 2000.</li><li><a class="nounderline abstract_t">Coccaro EF, Berman ME, McCloskey MS. Development of a screening questionnaire for DSM-5 intermittent explosive disorder (IED-SQ). Compr Psychiatry 2017; 74:21.</a></li><li><a class="nounderline abstract_t">Yoshimasu K, Kawakami N, WMH-J 2002-2006 Survey Group. Epidemiological aspects of intermittent explosive disorder in Japan; prevalence and psychosocial comorbidity: findings from the World Mental Health Japan Survey 2002-2006. Psychiatry Res 2011; 186:384.</a></li><li><a class="nounderline abstract_t">Bromet EJ, Gluzman SF, Paniotto VI, et al. Epidemiology of psychiatric and alcohol disorders in Ukraine: findings from the Ukraine World Mental Health survey. Soc Psychiatry Psychiatr Epidemiol 2005; 40:681.</a></li><li><a class="nounderline abstract_t">Lee S, Tsang A, Zhang MY, et al. Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychol Med 2007; 37:61.</a></li><li><a class="nounderline abstract_t">Al-Hamzawi A, Al-Diwan JK, Al-Hasnawi SM, et al. The prevalence and correlates of intermittent explosive disorder in Iraq. Acta Psychiatr Scand 2012; 126:219.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Fanning JR, Lee R. Intermittent Explosive Disorder and Substance Use Disorder: Analysis of the National Comorbidity Survey Replication Sample. J Clin Psychiatry 2017.</a></li><li><a class="nounderline abstract_t">Fincham D, Grimsrud A, Corrigall J, et al. Intermittent explosive disorder in South Africa: prevalence, correlates and the role of traumatic exposures. Psychopathology 2009; 42:92.</a></li><li><a class="nounderline abstract_t">Shen YC, Zhang MY, Huang YQ, et al. Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychol Med 2006; 36:257.</a></li><li class="breakAll">Coccaro EF, McCloskey MS. Phenomenology of impulsive aggression and intermittent explosive disorder. In: Intermittent Explosive Disorder: Etiology, Assessment, and Treatment, Coccaro EF, McCloskey MS (Eds), Academic Press, London 2019. p.37.</li><li><a class="nounderline abstract_t">Coccaro EF, Lee RJ. Disordered Aggression and Violence in the United States. J Clin Psychiatry 2020; 81.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Posternak MA, Zimmerman M. Prevalence and features of intermittent explosive disorder in a clinical setting. J Clin Psychiatry 2005; 66:1221.</a></li><li><a class="nounderline abstract_t">Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry 2008; 165:429.</a></li><li><a class="nounderline abstract_t">Bach-y-Rita G, Lion JR, Climent CE, Ervin FR. Episodic dyscontrol: a study of 130 violent patients. Am J Psychiatry 1971; 127:1473.</a></li><li><a class="nounderline abstract_t">Maletzky BM. The episodic dyscontrol syndrome. Dis Nerv Syst 1973; 34:178.</a></li><li><a class="nounderline abstract_t">Mattes JA, Fink M. A family study of patients with temper outbursts. J Psychiatr Res 1987; 21:249.</a></li><li><a class="nounderline abstract_t">Mattes JA, Fink M. A controlled family study of adopted patients with temper outbursts. J Nerv Ment Dis 1990; 178:138.</a></li><li><a class="nounderline abstract_t">Coccaro EF. A family history study of intermittent explosive disorder. J Psychiatr Res 2010; 44:1101.</a></li><li><a class="nounderline abstract_t">Miles DR, Carey G. Genetic and environmental architecture of human aggression. J Pers Soc Psychol 1997; 72:207.</a></li><li><a class="nounderline abstract_t">Coccaro EF, McCloskey MS, Fitzgerald DA, Phan KL. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biol Psychiatry 2007; 62:168.</a></li><li><a class="nounderline abstract_t">McCloskey MS, Phan KL, Angstadt M, et al. Amygdala hyperactivation to angry faces in intermittent explosive disorder. J Psychiatr Res 2016; 79:34.</a></li><li><a class="nounderline abstract_t">Ogbuagu N, Keedy S, Phan KL, Coccaro EF. Neural responses to induced emotion and response to social threat in intermittent explosive disorder. Psychiatry Res Neuroimaging 2021; 318:111388.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Lee R, McCloskey M, et al. Morphometric analysis of amygdla and hippocampus shape in impulsively aggressive and healthy control subjects. J Psychiatr Res 2015; 69:80.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Fitzgerald DA, Lee R, et al. Frontolimbic Morphometric Abnormalities in Intermittent Explosive Disorder and Aggression. Biol Psychiatry Cogn Neurosci Neuroimaging 2016; 1:32.</a></li><li><a class="nounderline abstract_t">Lee R, Arfanakis K, Evia AM, et al. White Matter Integrity Reductions in Intermittent Explosive Disorder. Neuropsychopharmacology 2016; 41:2697.</a></li><li><a class="nounderline abstract_t">Berman ME, McCloskey MS, Fanning JR, et al. Serotonin augmentation reduces response to attack in aggressive individuals. Psychol Sci 2009; 20:714.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Lee R, Kavoussi RJ. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder. J Psychiatr Res 2010; 44:137.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Lee R, Kavoussi RJ. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology 2010; 35:435.</a></li><li><a class="nounderline abstract_t">Frankle WG, Lombardo I, New AS, et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 2005; 162:915.</a></li><li><a class="nounderline abstract_t">van de Giessen E, Rosell DR, Thompson JL, et al. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB. J Psychiatr Res 2014; 58:147.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Lee R, Coussons-Read M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry 2014; 71:158.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Lee R, Fanning JR, et al. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects. Psychoneuroendocrinology 2016; 71:189.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Lee R, Gozal D. Elevated Plasma Oxidative Stress Markers in Individuals With Intermittent Explosive Disorder and Correlation With Aggression in Humans. Biol Psychiatry 2016; 79:127.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Irwin M, Arevalo JMG, et al. Gene expression in peripheral blood mononuclear cells in impulsive aggression: Intermittent explosive disorder compared with non-aggressive healthy and psychiatric controls. Psychoneuroendocrinology 2022; 136:105453.</a></li><li><a class="nounderline abstract_t">Coccaro EF, Lee R, Groer MW, et al. Toxoplasma gondii infection: relationship with aggression in psychiatric subjects. J Clin Psychiatry 2016; 77:334.</a></li><li><a class="nounderline abstract_t">Fanning JR, Meyerhoff J, Lee R, Coccaro EF. History of childhood maltreatment in intermittent explosive disorder and suicidal behavior. J Psychiatr Res 2014.</a></li></ol></div><div id="topicVersionRevision">Topic 112349 Version 5.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21295216" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Intermittent explosive disorder: development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22535310" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22535310" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16263865" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Impulse control disorders in adult psychiatric inpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27572872" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The cross-national epidemiology of DSM-IV intermittent explosive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27572872" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The cross-national epidemiology of DSM-IV intermittent explosive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28088746" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Development of a screening questionnaire for DSM-5 intermittent explosive disorder (IED-SQ).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20709410" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Epidemiological aspects of intermittent explosive disorder in Japan; prevalence and psychosocial comorbidity: findings from the World Mental Health Japan Survey 2002-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16160752" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Epidemiology of psychiatric and alcohol disorders in Ukraine: findings from the Ukraine World Mental Health survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17038208" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22443168" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The prevalence and correlates of intermittent explosive disorder in Iraq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28252880" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Intermittent Explosive Disorder and Substance Use Disorder: Analysis of the National Comorbidity Survey Replication Sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19225243" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Intermittent explosive disorder in South Africa: prevalence, correlates and the role of traumatic exposures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16332281" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16332281" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32220154" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Disordered Aggression and Violence in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16259534" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Prevalence and features of intermittent explosive disorder in a clinical setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18346997" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Neurobiology of aggression and violence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5551520" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Episodic dyscontrol: a study of 130 violent patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4736699" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The episodic dyscontrol syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3681760" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A family study of patients with temper outbursts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2299338" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A controlled family study of adopted patients with temper outbursts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20488459" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A family history study of intermittent explosive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9008382" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Genetic and environmental architecture of human aggression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17210136" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27145325" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Amygdala hyperactivation to angry faces in intermittent explosive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34706324" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Neural responses to induced emotion and response to social threat in intermittent explosive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26343598" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Morphometric analysis of amygdla and hippocampus shape in impulsively aggressive and healthy control subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29560894" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Frontolimbic Morphometric Abnormalities in Intermittent Explosive Disorder and Aggression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27206265" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : White Matter Integrity Reductions in Intermittent Explosive Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19422623" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Serotonin augmentation reduces response to attack in aggressive individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19767013" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19776731" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15863793" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25145808" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24352431" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27318828" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24582164" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Elevated Plasma Oxidative Stress Markers in Individuals With Intermittent Explosive Disorder and Correlation With Aggression in Humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34864503" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Gene expression in peripheral blood mononuclear cells in impulsive aggression: Intermittent explosive disorder compared with non-aggressive healthy and psychiatric controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27046307" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Toxoplasma gondii infection: relationship with aggression in psychiatric subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : History of childhood maltreatment in intermittent explosive disorder and suicidal behavior</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
